Drugs / OPC-41601
last change Jan 2009 re-read 2 minutes ago

OPC-41601

Developed for
cirrhosis of liver
Investigated by
Otsuka Pharmaceutical Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00479336 Jun 2007 → Jan 2009 cirrhosis of liver Otsuka Pharmaceutical Co., Ltd. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as OPC-41601 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00479336